Author details

Full Name

Drew Weissman

Affiliation

ORCID

Career Start Year

1982

Papers

211

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38084956	Hepatitis C virus modified sE2<sub>F442NYT</sub> as an antigen in candidate vaccine facilitates human immune cell activation.	J Virol	2024
37162920	Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.		2023
36136090	Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens.	Allergy: European Journal of Allergy and Clinical Immunology	2023
37606244	Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers.		2023
37602495	Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering.	Adv Healthc Mater	2023
37850965	The Regulation of Nucleic Acid Vaccine Responses by the Microbiome.		2023
37567884	Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.		2023
37556502	Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.		2023
37286568	A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria.		2023
37407406	Specific mRNA lipid nanoparticles and acquired resistance to ticks.		2023
37085495	Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice.		2023
36650129	Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis.		2023
37398465	Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke.	bioRxiv	2023
36824851	The Regulation of Nucleic Acid Vaccine Responses by the Microbiome.		2023
36706177	Ionizable lipid nanoparticles deliver mRNA to pancreatic Î² cells via macrophage-mediated gene transfer.		2023
37458484	Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease.	ACS Nano	2023
36947620	Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding.		2023
37131823	VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.		2023
36805684	Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals.	Commun Biol	2023
36934116	Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity.	NPJ Vaccines	2023
37376020	Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids.		2023
36930811	Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury.		2023
37432926	Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain.	ACS Nano	2023
37365276	Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.		2023
36789893	Ionizable Lipid Nanoparticles for mRNA Delivery to the Placenta during Pregnancy.		2023
36533954	Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.		2023
37537704	Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta.		2023
37533256	Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.		2023
37515169	A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.	Viruses	2023
37499029	In vivo hematopoietic stem cell modification by mRNA delivery.		2023
34871810	Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials.		2022
36376393	Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial.	Nat Microbiol	2022
36311701	mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model.	Frontiers in Immunology	2022
36103514	Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.	Sci Transl Med	2022
35704995	Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.	Immunity	2022
35569584	Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.	Journal of Controlled Release	2022
36274085	Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.	Nat Commun	2022
36334423	SARS-CoV-2 mRNA-based vaccines in the Aicardi GoutiÃ¨res Syndrome.	Molecular Genetics and Metabolism	2022
35616998	Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment.	Journal of the American Chemical Society	2022
35612312	Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response.	J Virol	2022
35857583	Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination.	Science immunology	2022
36423275	A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.	Science	2022
36380763	Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals.	Res Sq	2022
36591298	Exploring expression and immune potency in mice using mRNA encoding the malaria antigen, CelTOS.		2022
36498833	Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity.		2022
36456563	mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.	npj Vaccines	2022
36597546	Lipid Nanoparticle Composition Drives mRNA Delivery to the Placenta.		2022
32300916	Messenger RNA-Based Vaccines Against Infectious Diseases.	Current Topics in Microbiology and Immunology	2022
34990237	CAR T cells produced in vivo to treat cardiac injury.	Science	2022
34801660	Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery.	Journal of Controlled Release	2022